Evidence map›Paper›PMID 25856443›Full record

ArticlePloS one2015

Multi-parametric MRI at 14T for muscular dystrophy mice treated with AAV vector-mediated gene therapy.

Joshua Park, Jacqueline Wicki, Sue E Knoblaugh, Jeffrey S Chamberlain, Donghoon Lee

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Monitoring disease activity noninvasively in theProceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Joshua ParkDepartment of Radiology, University of Washington, Seattle, Washington, United States of America.
Jacqueline WickiDepartment of Neurology, University of Washington, Seattle, Washington, United States of America.
Sue E KnoblaughComparative Medicine Shared Resources, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Jeffrey S ChamberlainDepartment of Neurology, University of Washington, Seattle, Washington, United States of America; Department of Biochemistry, University of Washington, Seattle, Washington, United States of America; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
Donghoon LeeDepartment of Radiology, University of Washington, Seattle, Washington, United States of America.
University of Washington · USFred Hutch Cancer Center · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
Intellectual and Developmental Disabilities Research CenterU54HD083091 · NICHD · UNIVERSITY OF WASHINGTON · PI DOHERTY, DANIEL · 2014 to 2019
$7.9M
Vector Research Resource CoreU54AR065139 · NIAMS · UNIVERSITY OF WASHINGTON · PI CHAMBERLAIN, JEFFREY S · 2014 to 2017
$6.3M
Dystrophin Replacement in mdx miceR37AR040864 · NIAMS · UNIVERSITY OF WASHINGTON · PI CHAMBERLAIN, JEFFREY S · 2005 to 2014
$5.0M
Bruker Avance III 600 MHz (14T) Wide Bore SpectrometerS10RR029021 · NCRR · UNIVERSITY OF WASHINGTON · PI KUSHMERICK, MARTIN J · 2010 to 2010
$1.0M
New Reference Signal Injection Method for In Vivo QuantificationR21EB008166 · NIBIB · UNIVERSITY OF WASHINGTON · PI LEE, DONGHOON · 2009 to 2010
$427k
NCI NIH HHS P30 CA015704NCRR NIH HHS S10 RR029021NCRR NIH HHS S10RR029021NIAMS NIH HHS R37 AR040864NIAMS NIH HHS R37AR040864NIAMS NIH HHS U54 AR065139NIBIB NIH HHS R21 EB008166NIBIB NIH HHS R21EB008166NICHD NIH HHS U54 HD083091
6 · The paper itself

Abstract

The objective of this study was to investigate the efficacy of using quantitative magnetic resonance imaging (MRI) as a non-invasive tool for the monitoring of gene therapy for muscular dystrophy. The clinical investigations for this family of diseases often involve surgical biopsy which limits the amount of information that can be obtained due to the invasive nature of the procedure. Thus, other non-invasive tools may provide more opportunities for disease assessment and treatment responses. In order to explore this, dystrophic mdx4cv mice were systemically treated with a recombinant adeno-associated viral (AAV) vector containing a codon-optimized micro-dystrophin gene. Multi-parametric MRI of T2, magnetization transfer, and diffusion effects alongside 3-D volume measurements were then utilized to monitor disease/treatment progression. Mice were imaged at 10 weeks of age for pre-treatment, then again post-treatment at 8, 16, and 24 week time points. The efficacy of treatment was assessed by physiological assays for improvements in function and quantification of expression. Tissues from the hindlimbs were collected for histological analysis after the final time point for comparison with MRI results. We found that introduction of the micro-dystrophin gene restored some aspects of normal muscle histology and pathology such as decreased necrosis and resistance to contraction-induced injury. T2 relaxation values showed percentage decreases across all muscle types measured (tibialis anterior, gastrocnemius, and soleus) when treated groups were compared to untreated groups. Additionally, the differences between groups were statistically significant for the tibialis anterior as well. The diffusion measurements showed a wider range of percentage changes and less statistical significance while the magnetization transfer effect measurements showed minimal change. MR images displayed hyper-intense regions of muscle that correlated with muscle pathology in histological sections. T2 relaxation, alongside diffusion and magnetization transfer effects provides useful data towards the goal of non-invasively monitoring the treatment of muscular dystrophy.

Indexed as

AnimalsCreatine KinaseDependovirusDisease Models, AnimalDystrophinGenetic TherapyGenetic VectorsGene Transfer TechniquesImage Processing, Computer-AssistedMagnetic Resonance ImagingMiceMice, Inbred mdxMuscle, SkeletalMuscular Dystrophy, AnimalCreatine KinaseDystrophin

Identifiers

PMID25856443
PMCPMC4391935
OpenAlexW2042331443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.